How many insider declarations has venBio Global Strategic Fund III, L.P. filed?

venBio Global Strategic Fund III, L.P. has filed 5 public insider declarations with SEC (Form 4).

What is venBio Global Strategic Fund III, L.P.'s role?

venBio Global Strategic Fund III, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does venBio Global Strategic Fund III, L.P. report trades for?

venBio Global Strategic Fund III, L.P. reports trades for 4 companies, including Elevation Oncology, Inc..

What is venBio Global Strategic Fund III, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2.7M€.

← Executives ★ Sign in to follow

VG

venBio Global Strategic Fund III, L.P.

Other

·SEC (Form 4)

Elevation Oncology, Inc.Ventyx Biosciences, Inc.RayzeBio, Inc.Artiva Biotherapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€271万

▼ 卖出（1 笔）

Browse the complete record of transactions filed by venBio Global Strategic Fund III, L.P.. Director active across 4 companies, notably Elevation Oncology, Inc.. In total, 5 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €2.7m. History available since 25 May 2022. The latest transaction was filed on 25 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.